Optical fiber cable provided with stabilized waterblocking material
First Claim
1. An optical fiber cable, which comprises:
- a core comprising at least one optical fiber transmission medium;
a sheath system which is disposed about said core; and
a filling composition of matter which is disposed about the transmission medium in said core, said filling composition of matter comprising a hydrocarbon, a block copolymer, a colloidal filler and an antioxidant system which includes a hindered phenol sulfide in combination with a metal deactivator selected from the group consisting of dialkyldithiophosphates and diaryldithiophosphates.
4 Assignments
0 Petitions

Accused Products

Abstract
A cable of this invention includes a core comprising a plurality of coated optical fibers and a filling composition of matter which is disposed about the fibers. Typically, the fibers and the filling material are diposed within a tubular member which is disposed within a sheath system. The sheath system include longitudinally extending strength members and a plastic jacket. The filling composition which fills interstices in the core is one which includes an oil constituent which is a relatively high molecular weight aliphatic hydrocarbon. The aliphatic hydrocarbon is a synthetic oil such as polyalphaolefin or mineral oil. A relatively large percent by weight of an antioxidant system is used to prevent thermal oxidative degradation of the filling material as well as of materials in contact with the filling material. Advantageously, for stabilization and metal deactivation, the composition includes zinc dialkyldithiophosphate or diaryldithiophosphate. A styreneethylene propylene copolymer is also included in order to reduce oil separation of the filling material. A fumed silica is used to impart gel properties to the material.
432 Citations
Analyte monitoring device and methods of use | ||
Patent #
US 7,885,699 B2
Filed 08/06/2010
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Biointerface membranes incorporating bioactive agents | ||
Patent #
US 7,875,293 B2
Filed 05/10/2004
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 7,885,697 B2
Filed 03/10/2005
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
System and methods for processing analyte sensor data | ||
Patent #
US 7,914,450 B2
Filed 05/03/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 7,905,833 B2
Filed 06/21/2005
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Dual electrode system for a continuous analyte sensor | ||
Patent #
US 7,896,809 B2
Filed 11/03/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 7,869,853 B1
Filed 08/06/2010
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
System and methods for processing analyte sensor data | ||
Patent #
US 7,955,261 B2
Filed 03/23/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 7,946,984 B2
Filed 03/10/2005
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
SYSTEMS AND METHODS FOR REPLACING SIGNAL ARTIFACTS IN A GLUCOSE SENSOR DATA STREAM | ||
Patent #
US 20110137601A1
Filed 02/09/2011
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 7,949,381 B2
Filed 04/11/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
SYSTEM AND METHODS FOR REPLACING SIGNAL ARTIFACTS IN A GLUCOSE SENSOR DATA STREAM | ||
Patent #
US 20110124997A1
Filed 01/27/2011
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
System and methods for processing analyte sensor data | ||
Patent #
US 7,933,639 B2
Filed 03/23/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring system and method | ||
Patent #
US 7,920,907 B2
Filed 06/07/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
System and methods for processing analyte sensor data | ||
Patent #
US 7,925,321 B2
Filed 03/23/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
SYSTEMS AND METHODS FOR REPLACING SIGNAL ARTIFACTS IN A GLUCOSE SENSOR DATA STREAM | ||
Patent #
US 20110118579A1
Filed 01/27/2011
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
System and methods for processing analyte sensor data | ||
Patent #
US 7,959,569 B2
Filed 03/23/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Systems and methods for replacing signal artifacts in a glucose sensor data stream | ||
Patent #
US 7,935,057 B2
Filed 01/14/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
SYSTEMS AND METHODS FOR REPLACING SIGNAL ARTIFACTS IN A GLUCOSE SENSOR DATA STREAM | ||
Patent #
US 20110130971A1
Filed 02/09/2011
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
SYSTEMS AND METHODS FOR REPLACING SIGNAL ARTIFACTS IN A GLUCOSE SENSOR DATA STREAM | ||
Patent #
US 20110118580A1
Filed 01/27/2011
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
SYSTEMS AND METHODS FOR REPLACING SIGNAL ARTIFACTS IN A GLUCOSE SENSOR DATA STREAM | ||
Patent #
US 20110130970A1
Filed 02/09/2011
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Systems and methods for replacing signal artifacts in a glucose sensor data stream | ||
Patent #
US 8,010,174 B2
Filed 08/22/2003
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
SYSTEM AND METHODS FOR PROCESSING ANALYTE SENSOR DATA | ||
Patent #
US 20110231141A1
Filed 05/31/2011
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
SYSTEMS AND METHODS FOR PROCESSING ANALYTE SENSOR DATA | ||
Patent #
US 20110218414A1
Filed 04/05/2011
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
SYSTEM AND METHODS FOR PROCESSING ANALYTE SENSOR DATA | ||
Patent #
US 20110231140A1
Filed 05/31/2011
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Blood glucose tracking apparatus | ||
Patent #
US 7,976,778 B2
Filed 06/22/2005
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Systems and methods for replacing signal artifacts in a glucose sensor data stream | ||
Patent #
US 7,998,071 B2
Filed 10/14/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Systems and methods for replacing signal artifacts in a glucose sensor data stream | ||
Patent #
US 8,005,525 B2
Filed 10/14/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 8,000,901 B2
Filed 08/09/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
System and methods for processing analyte sensor data | ||
Patent #
US 7,986,986 B2
Filed 03/23/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
TRANSCUTANEOUS ANALYTE SENSOR | ||
Patent #
US 20110231107A1
Filed 05/26/2011
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
System and methods for processing analyte sensor data | ||
Patent #
US 7,979,104 B2
Filed 05/26/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
SYSTEM AND METHODS FOR PROCESSING ANALYTE SENSOR DATA | ||
Patent #
US 20110231142A1
Filed 05/31/2011
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
System and methods for processing analyte sensor data | ||
Patent #
US 8,052,601 B2
Filed 08/20/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
System and methods for processing analyte sensor data | ||
Patent #
US 8,060,173 B2
Filed 08/01/2003
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 7,860,544 B2
Filed 03/07/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
MEMBRANE FOR USE WITH IMPLANTABLE DEVICES | ||
Patent #
US 20100087724A1
Filed 12/08/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
SYSTEMS AND METHODS FOR PROCESSING ANALYTE SENSOR DATA | ||
Patent #
US 20100179408A1
Filed 03/25/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
SYSTEMS AND METHODS FOR REPLACING SIGNAL ARTIFACTS IN A GLUCOSE SENSOR DATA STREAM | ||
Patent #
US 20100036223A1
Filed 10/14/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
SYSTEMS AND METHODS FOR REPLACING SIGNAL ARTIFACTS IN A GLUCOSE SENSOR DATA STREAM | ||
Patent #
US 20100030053A1
Filed 10/14/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
SIGNAL PROCESSING FOR CONTINUOUS ANALYTE SENSOR | ||
Patent #
US 20100030038A1
Filed 10/12/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
SIGNAL PROCESSING FOR CONTINUOUS ANALYTE SENSOR | ||
Patent #
US 20100016687A1
Filed 09/23/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
SYSTEMS AND METHODS FOR REPLACING SIGNAL ARTIFACTS IN A GLUCOSE SENSOR DATA STREAM | ||
Patent #
US 20100036222A1
Filed 10/14/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
SYSTEMS AND METHODS FOR REPLACING SIGNAL ARTIFACTS IN A GLUCOSE SENSOR DATA STREAM | ||
Patent #
US 20100240976A1
Filed 06/01/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
SYSTEM AND METHODS FOR PROCESSING ANALYTE SENSOR DATA | ||
Patent #
US 20100214104A1
Filed 05/03/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 7,774,145 B2
Filed 01/18/2006
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
SYSTEM AND METHODS FOR PROCESSING ANALYTE SENSOR DATA | ||
Patent #
US 20100168657A1
Filed 12/11/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
SYSTEM AND METHODS FOR PROCESSING ANALYTE SENSOR DATA | ||
Patent #
US 20100179406A1
Filed 03/23/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DesCom Inc.
|
TRANSCUTANEOUS ANALYTE SENSOR | ||
Patent #
US 20100228497A1
Filed 05/14/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
SYSTEM AND METHODS FOR PROCESSING ANALYTE SENSOR DATA | ||
Patent #
US 20100217557A1
Filed 01/20/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
SYSTEMS AND METHODS FOR REPLACING SIGNAL ARTIFACTS IN A GLUCOSE SENSOR DATA STREAM | ||
Patent #
US 20100240975A1
Filed 06/01/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
INTEGRATED RECEIVER FOR CONTINUOUS ANALYTE SENSOR | ||
Patent #
US 20100016698A1
Filed 09/23/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
TRANSCUTANEOUS ANALYTE SENSOR | ||
Patent #
US 20100305869A1
Filed 08/09/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
TRANSCUTANEOUS ANALYTE SENSOR | ||
Patent #
US 20100223013A1
Filed 05/14/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
SYSTEM AND METHODS FOR PROCESSING ANALYTE SENSOR DATA | ||
Patent #
US 20100185065A1
Filed 03/26/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
SIGNAL PROCESSING FOR CONTINUOUS ANALYTE SENSOR | ||
Patent #
US 20100030485A1
Filed 10/12/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
SIGNAL PROCESSING FOR CONTINUOUS ANALYTE SENSOR | ||
Patent #
US 20100010324A1
Filed 09/23/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
SIGNAL PROCESSING FOR CONTINUOUS ANALYTE SENSOR | ||
Patent #
US 20100045465A1
Filed 10/12/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
SYSTEM AND METHODS FOR PROCESSING ANALYTE SENSOR DATA | ||
Patent #
US 20100217106A1
Filed 05/03/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
TRANSCUTANEOUS ANALYTE SENSOR | ||
Patent #
US 20100179404A1
Filed 03/23/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
SIGNAL PROCESSING FOR CONTINUOUS ANALYTE SENSOR | ||
Patent #
US 20100030484A1
Filed 09/23/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
SYSTEM AND METHODS FOR PROCESSING ANALYTE SENSOR DATA | ||
Patent #
US 20100168543A1
Filed 12/11/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
SYSTEM AND METHODS FOR PROCESSING ANALYTE SENSOR DATA | ||
Patent #
US 20100217555A1
Filed 12/16/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
SYSTEMS AND METHODS FOR REPLACING SIGNAL ARTIFACTS IN A GLUCOSE SENSOR DATA STREAM | ||
Patent #
US 20100036216A1
Filed 10/14/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
TRANSCUTANEOUS ANALYTE SENSOR | ||
Patent #
US 20100223023A1
Filed 05/14/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
SYSTEM AND METHODS FOR PROCESSING ANALYTE SENSOR DATA | ||
Patent #
US 20100168542A1
Filed 12/11/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
System and methods for processing analyte sensor data | ||
Patent #
US 7,797,028 B2
Filed 04/14/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 7,713,574 B2
Filed 03/10/2005
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
SYSTEM AND METHODS FOR PROCESSING ANALYTE SENSOR DATA | ||
Patent #
US 20100168541A1
Filed 12/11/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
SIGNAL PROCESSING FOR CONTINUOUS ANALYTE SENSOR | ||
Patent #
US 20100022855A1
Filed 09/23/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
SIGNAL PROCESSING FOR CONTINUOUS ANALYTE SENSOR | ||
Patent #
US 20100010332A1
Filed 09/23/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
SIGNAL PROCESSING FOR CONTINUOUS ANALYTE SENSOR | ||
Patent #
US 20100010331A1
Filed 09/23/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
SYSTEMS AND METHODS FOR REPLACING SIGNAL ARTIFACTS IN A GLUCOSE SENSOR DATA STREAM | ||
Patent #
US 20100036215A1
Filed 10/14/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
SYSTEMS AND METHODS FOR REPLACING SIGNAL ARTIFACTS IN A GLUCOSE SENSOR DATA STREAM | ||
Patent #
US 20100036225A1
Filed 10/14/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 7,654,956 B2
Filed 03/10/2005
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
SYSTEMS AND METHODS FOR REPLACING SIGNAL ARTIFACTS IN A GLUCOSE SENSOR DATA STREAM | ||
Patent #
US 20100036224A1
Filed 10/14/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DecCom Inc.
|
Device and method for determining analyte levels | ||
Patent #
US 7,711,402 B2
Filed 12/22/2004
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
SYSTEM AND METHODS FOR PROCESSING ANALYTE SENSOR DATA | ||
Patent #
US 20100168544A1
Filed 12/11/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
TRANSCUTANEOUS ANALYTE SENSOR | ||
Patent #
US 20100174158A1
Filed 03/22/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
INTEGRATED RECEIVER FOR CONTINUOUS ANALYTE SENSOR | ||
Patent #
US 20100179401A1
Filed 03/25/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
SYSTEM AND METHODS FOR PROCESSING ANALYTE SENSOR DATA | ||
Patent #
US 20100168540A1
Filed 12/11/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
SYSTEM AND METHODS FOR PROCESSING ANALYTE SENSOR DATA | ||
Patent #
US 20100185072A1
Filed 03/23/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
SYSTEMS AND METHODS FOR REPLACING SIGNAL ARTIFACTS IN A GLUCOSE SENSOR DATA STREAM | ||
Patent #
US 20100179409A1
Filed 03/25/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
TRANSCUTANEOUS ANALYTE SENSOR | ||
Patent #
US 20100212583A1
Filed 05/06/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Transcutaneous medical device with variable stiffness | ||
Patent #
US 7,783,333 B2
Filed 03/10/2005
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
System and methods for processing analyte sensor data | ||
Patent #
US 7,778,680 B2
Filed 08/01/2003
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
TRANSCUTANEOUS ANALYTE SENSOR | ||
Patent #
US 20100223022A1
Filed 05/14/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
SYSTEMS AND METHODS FOR REPLACING SIGNAL ARTIFACTS IN A GLUCOSE SENSOR DATA STREAM | ||
Patent #
US 20100235106A1
Filed 05/25/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte Monitoring Device and Methods of Use | ||
Patent #
US 20100292553A1
Filed 07/29/2010
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
SILICA AND ALSO EPOXY RESINS | ||
Patent #
US 20100286311A1
Filed 02/10/2009
|
Current Assignee
Evonik Operations GmbH
|
Original Assignee
Evonik Degussa GmbH
|
Analyte sensor | ||
Patent #
US 7,857,760 B2
Filed 02/22/2006
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte measuring device | ||
Patent #
US 7,860,545 B2
Filed 02/26/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
SYSTEM AND METHODS FOR PROCESSING ANALYTE SENSOR DATA | ||
Patent #
US 20090012379A1
Filed 08/20/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 7,494,465 B2
Filed 06/21/2005
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
SIGNAL PROCESSING FOR CONTINUOUS ANALYTE SENSOR | ||
Patent #
US 20090043542A1
Filed 10/16/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
SIGNAL PROCESSING FOR CONTINUOUS ANALYTE SENSOR | ||
Patent #
US 20090043182A1
Filed 10/16/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
SIGNAL PROCESSING FOR CONTINUOUS ANALYTE SENSOR | ||
Patent #
US 20090043525A1
Filed 10/16/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
SIGNAL PROCESSING FOR CONTINUOUS ANALYTE SENSOR | ||
Patent #
US 20090043181A1
Filed 10/16/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
TRANSCUTANEOUS ANALYTE SENSOR | ||
Patent #
US 20090076361A1
Filed 11/18/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 7,497,827 B2
Filed 03/10/2005
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
DUAL ELECTRODE SYSTEM FOR A CONTINUOUS ANALYTE SENSOR | ||
Patent #
US 20090076356A1
Filed 11/03/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
SIGNAL PROCESSING FOR CONTINUOUS ANALYTE SENSOR | ||
Patent #
US 20090062635A1
Filed 11/03/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
TRANSCUTANEOUS ANALYTE SENSOR | ||
Patent #
US 20090124879A1
Filed 01/14/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
SYSTEMS AND METHODS FOR REPLACING SIGNAL ARTIFACTS IN A GLUCOSE SENSOR DATA STREAM | ||
Patent #
US 20090124878A1
Filed 01/14/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
SYSTEMS AND METHODS FOR REPLACING SIGNAL ARTIFACTS IN A GLUCOSE SENSOR DATA STREAM | ||
Patent #
US 20090124877A1
Filed 01/14/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
ANALYTE SENSOR | ||
Patent #
US 20090143659A1
Filed 11/07/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
TRANSCUTANEOUS ANALYTE SENSOR | ||
Patent #
US 20090143660A1
Filed 12/05/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
TRANSCUTANEOUS ANALYTE SENSOR | ||
Patent #
US 20090163791A1
Filed 02/23/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
TRANSCUTANEOUS ANALYTE SENSOR | ||
Patent #
US 20090192724A1
Filed 02/03/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
SYSTEMS AND METHODS FOR PROCESSING SENSOR DATA | ||
Patent #
US 20090192745A1
Filed 10/24/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
SIGNAL PROCESSING FOR CONTINUOUS ANALYTE SENSOR | ||
Patent #
US 20090203981A1
Filed 04/15/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
SYSTEMS AND METHODS FOR CUSTOMIZING DELIVERY OF SENSOR DATA | ||
Patent #
US 20090240193A1
Filed 02/20/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
System and methods for processing analyte sensor data | ||
Patent #
US 7,583,990 B2
Filed 04/14/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
SYSTEMS AND METHODS FOR PROCESSING, TRANSMITTING AND DISPLAYING SENSOR DATA | ||
Patent #
US 20090240120A1
Filed 02/20/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
SYSTEMS AND METHODS FOR BLOOD GLUCOSE MONITORING AND ALERT DELIVERY | ||
Patent #
US 20090240128A1
Filed 02/20/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
System and methods for processing analyte sensor data | ||
Patent #
US 7,599,726 B2
Filed 04/14/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Hair styling composition | ||
Patent #
US 20090252689A1
Filed 03/31/2009
|
Current Assignee
Rohm and Haas Company
|
Original Assignee
Rohm and Haas Company
|
Membrane for use with implantable devices | ||
Patent #
US 7,632,228 B2
Filed 01/29/2004
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte sensor | ||
Patent #
US 7,640,048 B2
Filed 02/22/2006
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
SIGNAL PROCESSING FOR CONTINUOUS ANALYTE SENSOR | ||
Patent #
US 20090299162A1
Filed 07/24/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
SYSTEM AND METHODS FOR PROCESSING ANALYTE SENSOR DATA | ||
Patent #
US 20080021666A1
Filed 10/01/2007
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
SYSTEMS AND METHODS FOR REPLACING SIGNAL DATA ARTIFACTS IN A GLUCOSE SENSOR DATA STREAM | ||
Patent #
US 20080033254A1
Filed 06/13/2007
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
TRANSCUTANEOUS ANALYTE SENSOR | ||
Patent #
US 20080071156A1
Filed 10/26/2007
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
TRANSCUTANEOUS ANALYTE SENSOR | ||
Patent #
US 20080194935A1
Filed 04/11/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
TRANSCUTANEOUS ANALYTE SENSOR | ||
Patent #
US 20080188731A1
Filed 04/11/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
SYSTEM AND METHODS FOR PROCESSING ANALYTE SENSOR DATA | ||
Patent #
US 20080195967A1
Filed 04/14/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
SYSTEM AND METHODS FOR PROCESSING ANALYTE SENSOR DATA | ||
Patent #
US 20080194937A1
Filed 04/14/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
INTEGRATED RECEIVER FOR CONTINUOUS ANALYTE SENSOR | ||
Patent #
US 20080287765A1
Filed 07/29/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
INTEGRATED RECEIVER FOR CONTINUOUS ANALYTE SENSOR | ||
Patent #
US 20080287764A1
Filed 07/29/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
SYSTEM AND METHODS FOR PROCESSING ANALYTE SENSOR DATA | ||
Patent #
US 20080306368A1
Filed 08/21/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Sensor head for use with implantable devices | ||
Patent #
US 7,471,972 B2
Filed 12/22/2004
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Systems and methods for processing analyte sensor data | ||
Patent #
US 20070016381A1
Filed 09/01/2006
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Systems and methods for replacing signal artifacts in a glucose sensor data stream | ||
Patent #
US 20070032706A1
Filed 08/02/2006
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte sensor | ||
Patent #
US 20070027370A1
Filed 08/10/2006
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Subsea power cable | ||
Patent #
US 20070044992A1
Filed 08/10/2006
|
Current Assignee
Nexans Incorporated
|
Original Assignee
Nexans Incorporated
|
Porous membranes for use with implantable devices | ||
Patent #
US 7,192,450 B2
Filed 08/22/2003
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Systems and methods for processing analyte sensor data | ||
Patent #
US 20070066873A1
Filed 09/01/2006
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
ANALYTE SENSOR | ||
Patent #
US 20070163880A1
Filed 03/01/2007
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
TRANSCUTANEOUS ANALYTE SENSOR | ||
Patent #
US 20070203966A1
Filed 03/23/2007
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
TRANSCUTANEOUS ANALYTE SENSOR | ||
Patent #
US 20070208246A1
Filed 04/11/2007
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
System and methods for processing analyte sensor data | ||
Patent #
US 7,276,029 B2
Filed 08/01/2003
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 20070232879A1
Filed 05/03/2007
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Subsea power cable | ||
Patent #
US 7,285,726 B2
Filed 08/10/2006
|
Current Assignee
Nexans Incorporated
|
Original Assignee
Nexans Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 20070265515A1
Filed 05/03/2007
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Methods and systems for inserting a transcutaneous analyte sensor | ||
Patent #
US 7,310,544 B2
Filed 03/10/2005
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Lubricant for central core fiber optic cable having stranded ribbons | ||
Patent #
US 6,256,439 B1
Filed 05/26/1999
|
Current Assignee
Furukawa Electric North America Incorporated
|
Original Assignee
Lucent Technologies Inc.
|
Stabilized filler compositions for cable and wire | ||
Patent #
US 6,080,929 A
Filed 03/25/1998
|
Current Assignee
Si Group USA usaa LLC
|
Original Assignee
Uniroyal Chemical Company Inc
|
Optical cable with filling material comprising an internal olefin oligomer | ||
Patent #
US 6,278,824 B1
Filed 05/25/1999
|
Current Assignee
Prysmian Cavi E Sistemi Italia Srl
|
Original Assignee
Pirelli Cavi e Sistemi S.P.A.
|
Optical cable fiber provided with a non-migrating antioxidant | ||
Patent #
US 6,424,771 B1
Filed 02/21/2000
|
Current Assignee
Fitel USA Corporation
|
Original Assignee
Fitel USA Corporation
|
Filling compound having alumina gelling agent | ||
Patent #
US 6,377,737 B1
Filed 02/21/2000
|
Current Assignee
Furukawa Electric North America Incorporated
|
Original Assignee
Lucent Technologies Inc.
|
Submarine cable having a centrally located tube containing optical fibers | ||
Patent #
US 5,463,711 A
Filed 07/29/1994
|
Current Assignee
ATT Submarine Systems Inc.
|
Original Assignee
ATT Inc.
|
Dielectric ribbon optical fiber cable | ||
Patent #
US 5,384,880 A
Filed 12/03/1993
|
Current Assignee
Alcatel SA
|
Original Assignee
Alcatel SA
|
Optical fiber cable with components having improved compatibility with waterblocking filling compositions | ||
Patent #
US 6,658,185 B2
Filed 02/22/2002
|
Current Assignee
Prysmian Cavi E Sistemi Italia Srl
|
Original Assignee
Pirelli Cavi e Sistemi S.P.A.
|
Water blocking gels compatible with polyolefin optical fiber cable buffer tubes and cables made therewith | ||
Patent #
US 6,085,009 A
Filed 05/12/1998
|
Current Assignee
Alcatel-Lucent SA
|
Original Assignee
Alcatel-Lucent SA
|
Water-resistant cable | ||
Patent #
US 6,577,796 B2
Filed 04/06/2001
|
Current Assignee
Prysmian Cavi E Sistemi Italia Srl
|
Original Assignee
Pirelli Cavi e Sistemi S.P.A.
|
Cable with a filling compound and method for the manufacture thereof | ||
Patent #
US 5,698,615 A
Filed 05/09/1996
|
Current Assignee
CCS Technology Inc.
|
Original Assignee
Siemens AG
|
Filling compound for fiber optical cables | ||
Patent #
US 5,737,469 A
Filed 06/03/1996
|
Current Assignee
SONNEBORN HOLDING LLC
|
Original Assignee
Witco Corporation
|
Cable grease composition and articles incorporating same | ||
Patent #
US 5,433,872 A
Filed 01/18/1994
|
Current Assignee
Rutherford Chemicals LLC
|
Original Assignee
CasChem Inc.
|
Transcutaneous medical device with variable stiffness | ||
Patent #
US 20060015024A1
Filed 03/10/2005
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
TRANSCUTANEOUS ANALYTE SENSOR | ||
Patent #
US 20060020189A1
Filed 03/10/2005
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
TRANSCUTANEOUS ANALYTE SENSOR | ||
Patent #
US 20060019327A1
Filed 03/10/2005
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
TRANSCUTANEOUS ANALYTE SENSOR | ||
Patent #
US 20060020188A1
Filed 03/10/2005
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
TRANSCUTANEOUS ANALYTE SENSOR | ||
Patent #
US 20060020190A1
Filed 03/10/2005
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
TRANSCUTANEOUS ANALYTE SENSOR | ||
Patent #
US 20060020187A1
Filed 03/10/2005
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
TRANSCUTANEOUS ANALYTE SENSOR | ||
Patent #
US 20060016700A1
Filed 06/21/2005
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
TRANSCUTANEOUS ANALYTE SENSOR | ||
Patent #
US 20060036145A1
Filed 06/21/2005
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
TRANSCUTANEOUS ANALYTE SENSOR | ||
Patent #
US 20060036144A1
Filed 06/21/2005
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
TRANSCUTANEOUS ANALYTE SENSOR | ||
Patent #
US 20060036143A1
Filed 03/10/2005
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
TRANSCUTANEOUS ANALYTE SENSOR | ||
Patent #
US 20060036142A1
Filed 03/10/2005
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
TRANSCUTANEOUS ANALYTE SENSOR | ||
Patent #
US 20060036139A1
Filed 03/10/2005
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
TRANSCUTANEOUS ANALYTE SENSOR | ||
Patent #
US 20060036141A1
Filed 03/10/2005
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte sensor | ||
Patent #
US 20060142651A1
Filed 02/22/2006
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte sensor | ||
Patent #
US 20060155180A1
Filed 02/22/2006
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte sensor | ||
Patent #
US 20060183984A1
Filed 02/22/2006
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Biointerface membranes incorporating bioactive agents | ||
Patent #
US 20060198864A1
Filed 05/03/2006
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Biointerface membranes incorporating bioactive agents | ||
Patent #
US 20060204536A1
Filed 05/03/2006
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
System and methods for processing analyte sensor data | ||
Patent #
US 20050027181A1
Filed 08/01/2003
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
System and methods for processing analyte sensor data | ||
Patent #
US 20050027463A1
Filed 08/01/2003
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Increasing bias for oxygen production in an electrode system | ||
Patent #
US 20050056552A1
Filed 07/21/2004
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Silicone composition for biocompatible membrane | ||
Patent #
US 20050090607A1
Filed 10/28/2003
|
Current Assignee
DECOM INC.
|
Original Assignee
DexCom Incorporated
|
Porous membranes for use with implantable devices | ||
Patent #
US 20050112169A1
Filed 08/22/2003
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Sensor head for use with implantable devices | ||
Patent #
US 20050103625A1
Filed 12/22/2004
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Device and method for determining analyte levels | ||
Patent #
US 20050177036A1
Filed 12/22/2004
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
SIGNAL PROCESSING FOR CONTINUOUS ANALYTE SENSOR | ||
Patent #
US 20050203360A1
Filed 12/08/2004
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Membrane for use with implantable devices | ||
Patent #
US 20040186362A1
Filed 01/29/2004
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Liquid light guide system for interior lighting | ||
Patent #
US 20030147261A1
Filed 12/31/2002
|
Current Assignee
Neil L. Mcclure, Victor Babbitt
|
Original Assignee
Neil L. Mcclure, Victor Babbitt
|
Systems and methods for replacing signal artifacts in a glucose sensor data stream | ||
Patent #
US 8,073,519 B2
Filed 10/14/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Systems and methods for replacing signal artifacts in a glucose sensor data stream | ||
Patent #
US 8,073,520 B2
Filed 05/25/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Porous membranes for use with implantable devices | ||
Patent #
US 8,118,877 B2
Filed 01/17/2007
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Systems and methods for replacing signal artifacts in a glucose sensor data stream | ||
Patent #
US 8,128,562 B2
Filed 10/14/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Systems and methods for replacing signal artifacts in a glucose sensor data stream | ||
Patent #
US 8,150,488 B2
Filed 10/14/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 8,160,669 B2
Filed 04/11/2007
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,162,829 B2
Filed 03/30/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Systems and methods for replacing signal artifacts in a glucose sensor data stream | ||
Patent #
US 8,167,801 B2
Filed 03/25/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 8,170,803 B2
Filed 03/10/2005
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,175,673 B2
Filed 11/09/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,177,716 B2
Filed 12/21/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Systems and methods for replacing signal artifacts in a glucose sensor data stream | ||
Patent #
US 8,195,265 B2
Filed 02/09/2011
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
System and methods for processing analyte sensor data | ||
Patent #
US 8,206,297 B2
Filed 12/16/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Signal processing for continuous analyte sensor | ||
Patent #
US 8,216,139 B2
Filed 09/23/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,224,413 B2
Filed 10/10/2008
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,226,558 B2
Filed 09/27/2010
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,226,557 B2
Filed 12/28/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,226,555 B2
Filed 03/18/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Systems and methods for replacing signal artifacts in a glucose sensor data stream | ||
Patent #
US 8,229,536 B2
Filed 05/27/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 8,229,534 B2
Filed 10/26/2007
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Systems and methods for blood glucose monitoring and alert delivery | ||
Patent #
US 8,229,535 B2
Filed 02/20/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte sensor | ||
Patent #
US 8,231,531 B2
Filed 06/01/2006
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,231,532 B2
Filed 04/30/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Systems and methods for processing analyte sensor data | ||
Patent #
US 8,233,959 B2
Filed 09/01/2006
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Signal processing for continuous analyte sensor | ||
Patent #
US 8,233,958 B2
Filed 10/12/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Blood glucose tracking apparatus and methods | ||
Patent #
US 8,236,242 B2
Filed 02/12/2010
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,235,896 B2
Filed 12/21/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Signal processing for continuous analyte sensor | ||
Patent #
US 8,251,906 B2
Filed 04/15/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,255,031 B2
Filed 03/17/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Signal processing for continuous analyte sensor | ||
Patent #
US 8,257,259 B2
Filed 10/16/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,260,392 B2
Filed 06/09/2008
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Systems and methods for replacing signal data artifacts in a glucose sensor data stream | ||
Patent #
US 8,260,393 B2
Filed 06/13/2007
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,265,726 B2
Filed 11/09/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Signal processing for continuous analyte sensor | ||
Patent #
US 8,265,725 B2
Filed 10/12/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Blood glucose tracking apparatus and methods | ||
Patent #
US 8,268,243 B2
Filed 12/28/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,273,022 B2
Filed 02/13/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,275,439 B2
Filed 11/09/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 8,275,437 B2
Filed 03/23/2007
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 8,280,475 B2
Filed 02/23/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Integrated receiver for continuous analyte sensor | ||
Patent #
US 8,282,550 B2
Filed 07/29/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Signal processing for continuous analyte sensor | ||
Patent #
US 8,282,549 B2
Filed 12/08/2004
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
System and methods for processing analyte sensor data | ||
Patent #
US 8,285,354 B2
Filed 03/23/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,287,454 B2
Filed 09/27/2010
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 8,290,560 B2
Filed 11/18/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Signal processing for continuous analyte sensor | ||
Patent #
US 8,290,561 B2
Filed 09/23/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
System and methods for processing analyte sensor data | ||
Patent #
US 8,290,562 B2
Filed 05/03/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Systems and methods for replacing signal artifacts in a glucose sensor data stream | ||
Patent #
US 8,292,810 B2
Filed 01/27/2011
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,306,598 B2
Filed 11/09/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 8,311,749 B2
Filed 05/26/2011
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte sensor inserter system | ||
Patent #
US 8,313,434 B2
Filed 03/01/2007
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 8,321,149 B2
Filed 06/29/2011
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
System and methods for processing analyte sensor data | ||
Patent #
US 8,332,008 B2
Filed 03/23/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,346,336 B2
Filed 03/18/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,346,337 B2
Filed 06/30/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
System and methods for replacing signal artifacts in a glucose sensor data stream | ||
Patent #
US 8,346,338 B2
Filed 01/27/2011
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,353,829 B2
Filed 12/21/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,357,091 B2
Filed 12/21/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,366,614 B2
Filed 03/30/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Systems and methods for processing sensor data | ||
Patent #
US 8,369,919 B2
Filed 10/24/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,372,005 B2
Filed 12/21/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Signal processing for continuous analyte sensor | ||
Patent #
US 8,374,667 B2
Filed 10/16/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,380,273 B2
Filed 04/11/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Calibration techniques for a continuous analyte sensor | ||
Patent #
US 8,386,004 B2
Filed 09/07/2011
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,391,945 B2
Filed 03/17/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
System and methods for processing analyte sensor data | ||
Patent #
US 8,394,021 B2
Filed 10/01/2007
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,409,131 B2
Filed 03/07/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Systems and methods for replacing signal artifacts in a glucose sensor data stream | ||
Patent #
US 8,412,301 B2
Filed 02/09/2011
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Systems and methods for processing sensor data | ||
Patent #
US 8,423,113 B2
Filed 10/24/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
System and methods for processing analyte sensor data | ||
Patent #
US 8,428,679 B2
Filed 03/26/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Systems and methods for replacing signal artifacts in a glucose sensor data stream | ||
Patent #
US 8,435,179 B2
Filed 01/27/2011
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
System and methods for processing analyte sensor data | ||
Patent #
US 8,442,610 B2
Filed 08/21/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 8,452,368 B2
Filed 01/14/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 8,457,708 B2
Filed 12/05/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 8,463,350 B2
Filed 05/14/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,465,425 B2
Filed 06/30/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Signal processing for continuous analyte sensor | ||
Patent #
US 8,469,886 B2
Filed 09/23/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,473,021 B2
Filed 07/31/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 8,474,397 B2
Filed 05/06/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 8,475,373 B2
Filed 07/17/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,480,580 B2
Filed 04/19/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Silica and also epoxy resins | ||
Patent #
US 8,480,846 B2
Filed 02/10/2009
|
Current Assignee
Evonik Operations GmbH
|
Original Assignee
Evonik Degussa GmbH
|
Transcutaneous analyte sensor | ||
Patent #
US 8,483,791 B2
Filed 04/11/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Dual electrode system for a continuous analyte sensor | ||
Patent #
US 8,483,793 B2
Filed 10/29/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Systems and methods for replacing signal artifacts in a glucose sensor data stream | ||
Patent #
US 8,491,474 B2
Filed 01/27/2011
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Sensor head for use with implantable devices | ||
Patent #
US 8,509,871 B2
Filed 10/28/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 8,515,519 B2
Filed 02/26/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 8,515,516 B2
Filed 03/10/2005
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 8,548,551 B2
Filed 05/14/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
System and methods for processing analyte sensor data | ||
Patent #
US 8,548,553 B2
Filed 06/22/2012
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 8,565,849 B2
Filed 05/14/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 8,565,848 B2
Filed 05/07/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 8,571,625 B2
Filed 05/14/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
System and methods for processing analyte sensor data | ||
Patent #
US 8,588,882 B2
Filed 12/16/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Systems and methods for customizing delivery of sensor data | ||
Patent #
US 8,591,455 B2
Filed 02/20/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,597,189 B2
Filed 03/03/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,612,159 B2
Filed 02/16/2004
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte sensor | ||
Patent #
US 8,615,282 B2
Filed 02/22/2006
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,617,071 B2
Filed 06/21/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
System and methods for processing analyte sensor data | ||
Patent #
US 8,622,905 B2
Filed 12/11/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,622,906 B2
Filed 12/21/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Dual electrode system for a continuous analyte sensor | ||
Patent #
US RE44,695 E1
Filed 05/01/2012
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,641,619 B2
Filed 12/21/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,649,841 B2
Filed 04/03/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,652,043 B2
Filed 07/20/2012
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Signal processing for continuous analyte sensor | ||
Patent #
US 8,657,745 B2
Filed 10/16/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Systems and methods for processing analyte sensor data | ||
Patent #
US 8,657,747 B2
Filed 04/05/2011
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,660,627 B2
Filed 03/17/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 8,663,109 B2
Filed 03/29/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,666,469 B2
Filed 11/16/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,668,645 B2
Filed 01/03/2003
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,670,815 B2
Filed 04/30/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,672,844 B2
Filed 02/27/2004
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Systems and methods for processing analyte sensor data | ||
Patent #
US 8,672,845 B2
Filed 03/25/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
System and methods for processing analyte sensor data | ||
Patent #
US 8,676,287 B2
Filed 12/11/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,688,188 B2
Filed 06/30/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 8,690,775 B2
Filed 04/11/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
System and methods for processing analyte sensor data | ||
Patent #
US 8,700,117 B2
Filed 12/08/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 8,731,630 B2
Filed 03/22/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,734,348 B2
Filed 03/17/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,734,346 B2
Filed 04/30/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,738,109 B2
Filed 03/03/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,744,545 B2
Filed 03/03/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Signal processing for continuous analyte sensor | ||
Patent #
US 8,747,315 B2
Filed 09/23/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte sensor | ||
Patent #
US 8,750,955 B2
Filed 11/02/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
System and methods for processing analyte sensor data | ||
Patent #
US 8,761,856 B2
Filed 04/27/2012
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Blood glucose tracking apparatus | ||
Patent #
US 8,765,059 B2
Filed 10/27/2010
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
System and methods for processing analyte sensor data | ||
Patent #
US 8,771,187 B2
Filed 05/31/2011
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
System and methods for processing analyte sensor data | ||
Patent #
US 8,774,888 B2
Filed 01/20/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,774,887 B2
Filed 03/24/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Systems and methods for replacing signal artifacts in a glucose sensor data stream | ||
Patent #
US 8,777,853 B2
Filed 04/04/2012
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
System and methods for processing analyte sensor data | ||
Patent #
US 8,788,006 B2
Filed 12/11/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
System and methods for processing analyte sensor data | ||
Patent #
US 8,788,008 B2
Filed 05/31/2011
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 8,788,007 B2
Filed 03/08/2012
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Systems and methods for replacing signal artifacts in a glucose sensor data stream | ||
Patent #
US 8,790,260 B2
Filed 10/14/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 8,792,953 B2
Filed 03/19/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Systems and methods for replacing signal artifacts in a glucose sensor data stream | ||
Patent #
US 8,795,177 B2
Filed 01/14/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
System and methods for processing analyte sensor data | ||
Patent #
US 8,801,612 B2
Filed 04/27/2012
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Signal processing for continuous analyte sensor | ||
Patent #
US 8,801,610 B2
Filed 07/24/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
System and methods for processing analyte sensor data | ||
Patent #
US 8,808,182 B2
Filed 04/27/2012
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Transcutaneous medical device with variable stiffness | ||
Patent #
US 8,812,072 B2
Filed 04/17/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Systems and methods for replacing signal artifacts in a glucose sensor data stream | ||
Patent #
US 8,812,073 B2
Filed 06/01/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Systems and methods for replacing signal artifacts in a glucose sensor data stream | ||
Patent #
US 8,821,400 B2
Filed 02/09/2011
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 8,825,127 B2
Filed 05/14/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Membrane for use with implantable devices | ||
Patent #
US 8,840,552 B2
Filed 12/08/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,840,553 B2
Filed 02/26/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Systems and methods for replacing signal artifacts in a glucose sensor data stream | ||
Patent #
US 8,843,187 B2
Filed 06/01/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 8,845,536 B2
Filed 04/11/2007
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 8,858,434 B2
Filed 03/10/2005
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,880,137 B2
Filed 04/18/2003
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte sensor | ||
Patent #
US 8,886,273 B2
Filed 11/07/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte sensor | ||
Patent #
US 8,886,272 B2
Filed 02/22/2006
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 8,915,849 B2
Filed 02/03/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,915,850 B2
Filed 03/28/2014
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,920,319 B2
Filed 12/28/2012
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,974,386 B2
Filed 11/01/2005
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 8,986,209 B2
Filed 07/13/2012
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 8,989,833 B2
Filed 03/10/2005
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 9,011,332 B2
Filed 10/30/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 9,011,331 B2
Filed 12/29/2004
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 9,014,773 B2
Filed 03/07/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Systems and methods for processing, transmitting and displaying sensor data | ||
Patent #
US 9,020,572 B2
Filed 09/10/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 9,042,953 B2
Filed 03/02/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 9,044,199 B2
Filed 03/10/2005
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 9,055,901 B2
Filed 09/14/2012
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 9,060,742 B2
Filed 03/19/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 9,066,695 B2
Filed 04/12/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 9,066,697 B2
Filed 10/27/2011
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 9,066,694 B2
Filed 04/03/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 9,072,477 B2
Filed 06/21/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 9,078,626 B2
Filed 03/31/2011
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 9,078,607 B2
Filed 06/17/2013
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Signal processing for continuous analyte sensor | ||
Patent #
US 9,107,623 B2
Filed 04/15/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Systems and methods for processing, transmitting and displaying sensor data | ||
Patent #
US 9,143,569 B2
Filed 02/20/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Systems and methods for replacing signal artifacts in a glucose sensor data stream | ||
Patent #
US 9,149,219 B2
Filed 02/09/2011
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Signal processing for continuous analyte sensor | ||
Patent #
US 9,192,328 B2
Filed 09/23/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte sensor | ||
Patent #
US 9,247,900 B2
Filed 06/04/2013
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Systems and methods for replacing signal artifacts in a glucose sensor data stream | ||
Patent #
US 9,247,901 B2
Filed 08/02/2006
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Systems and methods for replacing signal artifacts in a glucose sensor data stream | ||
Patent #
US 9,282,925 B2
Filed 03/25/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 9,326,716 B2
Filed 12/05/2014
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Sensor head for use with implantable devices | ||
Patent #
US 9,328,371 B2
Filed 07/16/2013
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 9,326,714 B2
Filed 06/29/2010
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Signal processing for continuous analyte sensor | ||
Patent #
US 9,351,668 B2
Filed 10/12/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Signal processing for continuous analyte sensor | ||
Patent #
US 9,364,173 B2
Filed 09/23/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 9,414,777 B2
Filed 03/10/2005
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Signal processing for continuous analyte sensor | ||
Patent #
US 9,420,965 B2
Filed 07/01/2011
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Systems and methods for replacing signal artifacts in a glucose sensor data stream | ||
Patent #
US 9,420,968 B2
Filed 04/04/2012
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Systems and methods for replacing signal artifacts in a glucose sensor data stream | ||
Patent #
US 9,427,183 B2
Filed 07/12/2011
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte sensor | ||
Patent #
US 9,451,908 B2
Filed 12/19/2012
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Blood glucose tracking apparatus and methods | ||
Patent #
US 9,477,811 B2
Filed 06/23/2005
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 9,498,159 B2
Filed 10/30/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Signal processing for continuous analyte sensor | ||
Patent #
US 9,498,155 B2
Filed 10/16/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Systems and methods for replacing signal artifacts in a glucose sensor data stream | ||
Patent #
US 9,510,782 B2
Filed 04/04/2012
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Membrane for use with implantable devices | ||
Patent #
US 9,532,741 B2
Filed 07/25/2014
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Integrated receiver for continuous analyte sensor | ||
Patent #
US 9,538,946 B2
Filed 03/25/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Systems and methods for replacing signal artifacts in a glucose sensor data stream | ||
Patent #
US 9,585,607 B2
Filed 04/04/2012
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 9,603,557 B2
Filed 05/13/2013
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 9,610,034 B2
Filed 11/09/2015
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 9,610,031 B2
Filed 04/13/2011
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Systems and methods for replacing signal artifacts in a glucose sensor data stream | ||
Patent #
US 9,649,069 B2
Filed 06/29/2016
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte sensor | ||
Patent #
US 9,668,677 B2
Filed 10/26/2015
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Systems and methods for processing sensor data | ||
Patent #
US 9,717,449 B2
Filed 01/15/2013
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Systems and methods for replacing signal artifacts in a glucose sensor data stream | ||
Patent #
US 9,724,045 B1
Filed 04/06/2017
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Signal processing for continuous analyte sensor | ||
Patent #
US 9,750,441 B2
Filed 08/15/2016
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Systems and methods for replacing signal artifacts in a glucose sensor data stream | ||
Patent #
US 9,750,460 B2
Filed 04/14/2017
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 9,775,543 B2
Filed 12/30/2013
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 9,801,572 B2
Filed 06/18/2015
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Sensor head for use with implantable devices | ||
Patent #
US 9,804,114 B2
Filed 03/02/2016
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 9,814,414 B2
Filed 03/30/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 9,833,143 B2
Filed 06/05/2014
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 9,833,176 B2
Filed 07/12/2012
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
System and methods for processing analyte sensor data | ||
Patent #
US 9,895,089 B2
Filed 05/20/2014
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte sensor | ||
Patent #
US 9,986,942 B2
Filed 08/10/2006
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte sensor | ||
Patent #
US 10,022,078 B2
Filed 05/23/2006
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Membrane for use with implantable devices | ||
Patent #
US 10,039,480 B2
Filed 02/11/2015
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Systems and methods for processing sensor data | ||
Patent #
US 10,182,751 B2
Filed 06/26/2017
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 10,201,301 B2
Filed 04/18/2016
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 10,231,654 B2
Filed 06/23/2015
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte sensor | ||
Patent #
US 10,314,525 B2
Filed 01/06/2015
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 10,327,638 B2
Filed 10/30/2017
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte sensor | ||
Patent #
US 10,349,873 B2
Filed 04/27/2016
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 10,478,108 B2
Filed 02/05/2016
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 10,524,703 B2
Filed 01/24/2014
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
System and methods for processing analyte sensor data for sensor calibration | ||
Patent #
US 10,610,137 B2
Filed 06/28/2019
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
System and methods for processing analyte sensor data for sensor calibration | ||
Patent #
US 10,610,136 B2
Filed 06/28/2019
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
System and methods for processing analyte sensor data for sensor calibration | ||
Patent #
US 10,610,135 B2
Filed 06/28/2019
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
System and methods for processing analyte sensor data for sensor calibration | ||
Patent #
US 10,617,336 B2
Filed 06/28/2019
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Integrated insulin delivery system with continuous glucose sensor | ||
Patent #
US 10,653,835 B2
Filed 10/24/2017
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
System and methods for processing analyte sensor data for sensor calibration | ||
Patent #
US 10,709,364 B2
Filed 11/21/2019
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte sensor | ||
Patent #
US 10,709,362 B2
Filed 11/21/2019
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte sensor | ||
Patent #
US 10,709,363 B2
Filed 11/21/2019
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
System and methods for processing analyte sensor data for sensor calibration | ||
Patent #
US 10,716,498 B2
Filed 11/21/2019
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte sensor | ||
Patent #
US 10,722,152 B2
Filed 11/05/2019
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
System and methods for processing analyte sensor data for sensor calibration | ||
Patent #
US 10,743,801 B2
Filed 11/21/2019
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
System and methods for processing analyte sensor data | ||
Patent #
US 10,786,185 B2
Filed 01/05/2018
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte sensor | ||
Patent #
US 10,799,158 B2
Filed 11/21/2019
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte sensor | ||
Patent #
US 10,799,159 B2
Filed 02/13/2020
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte sensor | ||
Patent #
US 10,813,577 B2
Filed 02/13/2020
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte sensor | ||
Patent #
US 10,813,576 B2
Filed 11/21/2019
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Integrated insulin delivery system with continuous glucose sensor | ||
Patent #
US 10,835,672 B2
Filed 05/05/2020
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
System and methods for processing analyte sensor data for sensor calibration | ||
Patent #
US 10,856,787 B2
Filed 07/31/2019
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Depressed cladding optical fiber cable | ||
Patent #
US 4,836,640 A
Filed 06/27/1986
|
Current Assignee
Fitel USA Corporation
|
Original Assignee
American Telephone Telegraph
|
Optical fiber cable having dripless, non-bleeding and optical fiber coating-compatible waterblocking material in core thereof | ||
Patent #
US 5,187,763 A
Filed 04/26/1991
|
Current Assignee
Furukawa Electric North America Incorporated
|
Original Assignee
American Telephone Telegraph
|
Optical fiber cable including a plurality of multifiber units within a single tube and methods of making | ||
Patent #
US 4,826,278 A
Filed 03/25/1988
|
Current Assignee
Fitel USA Corporation
|
Original Assignee
ATT Teleholdings Incorporated, American Telephone Telegraph
|
Thixotropic grease composition and cable comprising same | ||
Patent #
US 4,701,016 A
Filed 01/31/1985
|
Current Assignee
Fitel USA Corporation
|
Original Assignee
American Telephone Telegraph
|
Optical fiber cable | ||
Patent #
US 4,844,575 A
Filed 04/10/1987
|
Current Assignee
Fitel USA Corporation
|
Original Assignee
ATT Teleholdings Incorporated, American Telephone Telegraph
|
Process for the preparation of thermoplastic elastomers | ||
Patent #
US 4,803,244 A
Filed 11/16/1987
|
Current Assignee
Union Carbide Corporation Old Ridgebury Road Danbury CT 06817
|
Original Assignee
Union Carbide Corporation
|
12 Claims
-
1. An optical fiber cable, which comprises:
-
a core comprising at least one optical fiber transmission medium; a sheath system which is disposed about said core; and a filling composition of matter which is disposed about the transmission medium in said core, said filling composition of matter comprising a hydrocarbon, a block copolymer, a colloidal filler and an antioxidant system which includes a hindered phenol sulfide in combination with a metal deactivator selected from the group consisting of dialkyldithiophosphates and diaryldithiophosphates. - View Dependent Claims (2, 3, 4, 5, 6)
-
- 7. A composition of matter for filling optical fiber cables comprising a hydrocarbon, a block copolymer, a colloidal filler and an antioxidant system which includes a hindered phenol sulfide in combination with a metal deactivator selected from the group consisting of dialkyldithiosphates and diaryldithiophosphates.
1 Specification
This invention relates to an optical fiber cable provided with a stabilized waterblocking material. More particularly, the invention relates to a cable provided with a dripless, non-bleeding, optical fiber coating-compatible and stabilized waterblocking material which fills interstices in a core of the cable.
In the cable industry, it is well known that changes in ambient conditions lead to differences in water vapor pressure between the inside and the outside of a plastic cable jacket. This generally operates to diffuse moisture in a unidirectional manner from the ouside of the cable to the inside of the cable. Eventually, this will lead to an undesirably high moisture level inside the cable, especially if a plastic jacket is the only barrier to the ingress of the moisture. High levels of condensed moisture inside a cable sheath system may have a detrimental effect on the transmission characteristics of a metallic conductor cable.
Furthermore, water may enter the cable because of damage to the cable which compromises its integrity. For example, rodent attacks or mechanical impacts may cause openings in the sheath system of the cable to occur, allowing water to enter, and, if not controlled, to move longitudinally along the cable into splice closures.
In the prior art, various techniques have been used to prevent the ingress of water through the sheath system of a cable and along the core. For example, a metallic shield which often times is used to protect a metallic conductor cable against lightning and rodent attacks is provided with a sealed longitudinal seam. However, the forming of a shield about a cable core requires the use of relatively low manufacturing line speeds. Also, the use of a metallic shield is destructive of the otherwise all-dielectric property of an optical fiber cable. Further, lightning strikes may cause holes in a metallic shield.
It is not uncommon to include provisions in addition to or as an alternative to a metallic shield for preventing the ingress of water into the core. Waterblocking materials have been used to fill cable cores and to coat portions of cable sheath systems to prevent the movement longitudinally thereof of any water which enters the cable. Such a material, typically is referred to as a filling material. In optical fiber cables, a further important function of a filling material is the maintenance of the optical fibers in a low stress state.
As taught in the prior art, U.S. Ser. No. 07/691,770 filed on Apr. 26, 1991 in the name of C. F. Tu, now U.S. Pat. No. 5,187,763, a cable filling material, especially an optical fiber cable filling material, should meet a variety of requirements. Among them is the requirement that the physical properties of the cable remain within acceptable limits over a rather wide temperature range e.g., from about -40° to about 76° C. It is desirable that the composition of matter of the filling material be substantially free of syneresis, i.e. have an ability to retain uniform consistency, over the temperature range. Generally, syneresis is controlled by assuring dispersion of an adequate amount of colloidal particles or other gelling agent. Other desirable properties of the compositions include thermal oxidation resistance.
Optical fiber cables have made great inroads into the communications cable market. Although the presence of water itself within an optical fiber cable is not necessarily detrimental to its performance, passage of the water along the cable interior to connection points or terminals or associated equipment inside closures, for example, may cause problems. In both cases, under freezing conditions, the performance of optical fiber deteriorates quickly.
Further complicating the optical fiber cable situation is the introduction of a waterblocking filling material into the cable core in order to prevent the incursion of water. Suitable waterblocking materials in use must yield under strains experienced when the cable is made or handled. Otherwise, movement of the optical fibers within the cable would be prevented and the fibers would buckle because they contact, with a relative small periodicity, a surface of the unyielding filling material. The smaller the periodicity of the fibers when contacting such an unyielding surface, the greater a loss which is referred to as microbending loss.
Typically, microbending loss in optical fiber cables is more difficult to control at long wavelengths than at short ones. Thus the requirements on the mechanical properties of a fiber cable filling material are typically substantially more severe for cable that is to be used at 1.55 μm, for example, than they are if the cable is to be used at shorter operating wavelengths of 1.3 μm, for example. Although, it has been found that some prior art filling materials perform quite satisfactorily at wavelengths up to about 1.3 μm, it has also been found that this is often not the case at longer wavelengths.
Because silica-based optical fibers typically have their lowest losses at or near the 1.55 μm wavelength, there is great interest in operating optical fiber telecommunication systems at approximately that wavelength. Thus, it is important to have available filling compositions for optical fiber cable that has no significant cabling-induced losses at long wavelengths, including about 1.55 μm.
Filling compositions for use in optical fiber cables should have a relatively low shear modulus, Ge. However, it has been determined that, at least for some applications, a low value of Ge of the filling material is not sufficient to assure low cabling loss, and that a further parameter, the critical yield stress, σc, needs to be controlled because it also affects the optical performance of fibers in a cable with a filling material.
Incorporating a block copolymer into the grease-like composition of matter allows a reduction of the amount of colloidal particles that has been added to the mixture to prevent syneresis of the gel. This reduction can result in cost savings. Furthermore, it makes possible the formulation of less bleeding compositions having a very low critical yield stress.
Waterproofing filling materials for use in cables also must pass industry standard drip tests. To pass these tests, filling materials in cable cores must be retained as cable samples, suspended vertically, and subjected to specified elevated temperatures. Some prior art materials, which have been used, perform satisfactorily with respect to microbending and associated losses, but they bleed out excessively and have problems in meeting current drip tests. Also, it is desired that the low mean added losses exhibited by some prior art filling materials at least be met by filling materials which pass the drip test and have suitable low temperature properties.
Oil separation is a property of a grease-like material which describes the tendency to bleed oil during its lifetime. What is desired is a filling material which has an oil separation no greater than 5% when centrifuged at a rotational speed equivalent to a relative centrifugal force of about 26,000 G. for two hours.
The viscosity of the sought after filling material also is important with respect to processing. Because cable drip is related to oil separation, constraints on the sought after filling material include oil separation, critical yield stress and viscosity. These constraints usually are antagonistic to each other. For example, a reduction of oil separation and an increase in cable drip temperature require high viscosity and yield stress whereas to facilitate processing and to reduce optical loss requires low viscosity and yield stress.
Another problem relating to filled optical fiber cables is the compatibility of the filling material with some coating materials which are disposed about drawn optical fiber to protect the optical fiber. If compatibility is lacking, the performance and/or the appearance of the optical fiber could be affected adversely. The compatibility of otherwise suitable prior art filling materials with some coating materials, particularly those which are relatively soft, is something less than desired.
The filling composition of matter is one which includes an oil constituent which is a relatively high molecular weight aliphatic hydrocarbon. The aliphatic hydrocarbon constituent may be a synthetic oil or mineral oil such as polyalphaolefin, for example, or a relatively high molecular weight mineral oil. Relatively low pour point oils are used in order to improve optical loss at low temperatures. A relatively large percent by weight of an antioxidant system is used to prevent thermal oxidative degradation of the filling material as well as of materials in contact with the filling material. A low molecular weight copolymer is also used to reduce oil separation of the filling material.
Although the above-mentioned composition is suitable from many standpoints for ease in waterblocking in an optical fiber cable, there is a desire to improve cost and performance of the composition.
What is sought after is a waterblocking composition which has a lower cost and improved performance over those used in the past. More particularly one of the constituents may not only give improved performance but also may provide synergistic properties.
The foregoing perfomance problems of the prior art have been improved by a cable of this invention having a filling composition of matter disposed in a core thereof. A cable of this invention includes a core comprising a plurality of coated optical fibers and a filling composition of matter which is disposed about the fibers. Typically, the fibers and the filling material are disposed within a tubular member which is disposed within a sheath system. The sheath system includes longitudinally extending strength members and a plastic jacket.
The filling composition which fills interstices in the core is one which includes an oil constituent which is a relatively high molecular weight aliphatic hydrocarbon. The aliphatic hydrocarbon is a synthetic oil or mineral oil such as polyalphaolefin. A relatively large percent by weight of an antioxidant system is used to prevent thermal oxidative degradation of the filling material as well as of materials in contact with the filling material. Advantageously, for stabilization and metal deactivation, the composition includes zinc dialkyldithiophosphate or zinc diaryldithiophosphate. A styrene-ethylene propylene copolymer is included in order to reduce oil separation of the filling material. A fumed silica is also used to impart gel properties to the material.
Other features of the present invention will be more readily understood from the following detailed description of specific embodiments thereof when read in conjunction with the accompanying drawings, in which:
FIG. 1 is a perspective view of an optical fiber cable of this invention which has a core in which is disposed a filling material;
FIG. 2 is an end view in section of the cable of FIG. 1;
Referring now to FIGS. 1 and 2, there is shown a communications cable which may incorporate the improved filling material of the present invention and which is designated generally by the numeral 20 and which has a longitudinal axis 21. It includes a core 22 comprising optical fibers 25--25 which may be arranged in one or more units 24--24. Each of the optical fibers is provided with a protective coating system which typically includes an inner primary coating layer and an outer secondary coating layer. Also, each of the coated fibers may be buffered with an outer layer of polyvinyl chloride (PVC), for example. Each of the units 24--24 may be wrapped with a binder ribbon 23. The core 22 includes a waterblocking material 26 which is disposed within a tubular member 28 of a sheath system 27. The tubular member 28 often is referred to as a core tube.
The tubular member 28 may be enclosed by a metallic shield 29 and an outer plastic jacket 32. The sheath system 27 also may include strength members 30--30. Also, a waterblocking tape 35 may be wrapped about an outer surface of the core tube 28. The tape 35 may be a waterblocking tape which is disclosed, for example, in U.S. Pat. No. 4,867,526 which issued on Sep. 19, 1989 in the name of C. J. Arroyo. Also, the filling material 26 may be used to fill the core of a cable which includes optical fiber ribbons such as those disclosed in U.S. Pat. No. 4,900,176 which issued on Feb. 13, 1990 in the names of K. W. Jackson, et al.
Constraints on the sought after filling material which includes an oil constituent include oil separation, and associated cable drip temperature, critical yield stress and viscosity of the filling material. As mentioned hereinbefore, these constraints usually are antagonistic to each other. Priorly, it has been demonstrated that low pour point oils produce filling materials the critical yield stress of which at low temperatures decreases with decreasing pour point. The pour point of a material is the lowest temperature at which a sample of the material may be poured. Theoretically, the use of a low pour point oil is conducive to the reduction of optical loss at low temperatures. Cable construction and cable processing conditions also affect the optical performance of fibers and, therefore, the benefit of a low pour point oil may become obscured.
The critical yield stress of a filling material is considered to affect the optical performance of fibers in a cable filled with the filling material. The prior art filling material typically has a critical yield stress of 0.0016 psi at room temperature and 0.0096 psi at -40° C. The critical yield stress of the filling material 26 should be such that it does not cause an increase in optical fiber loss over that of prior art filling materials at all temperatures.
The viscosity requirement is needed to accommodate processing, not cable performance. The viscosity of prior art filling material as measured by a helipath viscometer should be 15 to 45 units using spindle TB at room temperature. In order to assure the waterhead resistance of an optical fiber cable, it is preferred to have the helipath viscosity in excess of 28 units. It is desired that the viscosity of the filling material be in the vicinity of that of prior art filling materials so that presently available processing facilities can be used.
The composition of matter of the filling material 26 which is used to fill interstices in the core of the cable 20 and which meets the foregoing requirements includes an oil constituent system in the range of about 85 to about 92 percent by weight. A suitable oil constituent is a relatively high molecular weight aliphatic hydrocarbon. By relatively high in this description is meant a molecular weight in excess of about 600.
The aliphatic hydrocarbon constituent may be a relatively high molecular weight mineral oil such as Kaydol available from the Witco Corporation, for example. In the alternative, the aliphatic hydrocarbon constituent may be a synthetic oil or mineral oil such as, polyalphaolefin oil, polypropene oil or polybutene oil for example. Mixtures of polyalphaolefin with mineral oils and polybutene oils also may be used. In a preferred embodiment, the composition includes about 86.7% by weight of a polyalphaolefin such as SHF 402 oil available from the Mobil Corporation. The synthetic oil or mineral oil of the preferred embodiment is a hydrogenated oligomer of alpha-decene and has an average molecular weight of 1280. The viscosity of the oil at 100° C. is approximately 40 centistokes. It has a pour point of approximately -40° C.
The polyalphaolefin aliphatic hydrocarbon also may be one which is characterized by a viscosity in the range of about 10 to 60 centistokes at 100° C. Suitable polybutene oils have a viscosity in the range of 190 to 300 centistokes whereas a suitable mineral oil has a viscosity greater than 150 SUS which equates to about 35 centistokes. If it has a viscosity substantially greater than 10 centistokes, such as, for example, 40 centistokes, the filling material may become more compatible with the coated optical fiber.
Importantly, included in the composition of the filling material 26 in accordance with the present invention is an antioxidant system in the amount of about 1.3% by weight. The antioxidant system of the preferred embodiment of this invention comprises two antioxidant constituents. In particular, one of the antioxidant constituents may be zinc diaryldithiophosphate or dialkyldithiophosphate (ZDDP). The other antioxidant constituent is high molecular weight, hindered phenolic sulfide which is relatively soluble in mineral oil. Acceptable ZDDP antioxidants are available from the Lubritol Corporation under the tradename Lubritol 1370, and 1395 while an acceptable constituent as the phenolic sulfide is available from the Ciba-Geigy Company under the trade designation Irganox 1035. In a preferred embodiment, the filling composition includes approximately 1.0% by weight of Lubritol 1370 and 0.3% by weight of Irganox 1035. This antioxidant system improves the performance of oil.
Advantageously, the ZDDP has other desirable properties. It also serves as an anti-corrosion agent Not to be overlooked is the reduced cost of ZDDP over other stabilizers.
Exemplary compositions of this invention are shown in TABLES I and II, with the constituents being given in percent by weight. A summary of properties also is presented in each TABLE. Included in the TABLES are measurements of the swell of the primary optical fiber coating material, viscosity, oil separation and yield stress at room temperature. Cable drip test results at 65° C. are also provided in some of the TABLES. PG,10
TABLE I__________________________________________________________________________COMPOSITION & PROPERTIES OF THE FILLING MATERIAL__________________________________________________________________________Composition (% by wt) Fumed Silica Copolymer Antioxidant Oil Cab-O-Sil Kraton Lubrizol Irganox LubrizolEx. Kaydol SHF 402 TS720 G1701 1395 1035 1370(1) (2) (3) (4) (5) (6) (7) (8)__________________________________________________________________________A -- 86.7 6.0 6.0 -- 0.3 1.0B -- 86.7 6.0 6.0 -- 0.3 1.0C -- 86.7 6.0 6.0 -- 0.3 1.0D -- 86.2 6.0 6.0 -- 0.3 1.5E 86.53 -- 6.0 6.0 1.17 0.3 --F 85.87 -- 6.0 6.0 1.83 0.3 --G 86.7 -- 6.0 6.0 -- 0.3 1.0H 90.0 -- 4.5 4.2 -- 0.3 1.0__________________________________________________________________________ Primary OIT Coating Hellpath Oil Yield at 220° C. Swell Viscosity Sep. Stress Drip TestEx. (min) (Vol. %) (Units) (%) (psi) at 65° C. at 70° C.(1) (9) (10) (11) (12) (13) (14) (15)__________________________________________________________________________A 26.5 -- 35.1 1.34 <0.002 Pass --B 28.6 5.03 32.4 2.14 0.0027 Pass --C 33.4 -- 33.5 1.63 0.0037 -- PassD 31.8 -- -- -- -- -- --E 49.5 0 -- -- -- -- --F 56.5 0 -- -- -- -- --G 45.1 0 -- -- -- -- --H 34.5 0 20.2 -- 0.0010 -- Pass__________________________________________________________________________
TABLE II__________________________________________________________________________STABILIZATION FOR FILLING COMPOUNDKraton G-1701, 6 g; CAB-O-SIL TS 720, 6 g; LUBRIZOL LUBRIZOL 1370 1395 IRGANOX IRGANOX (60%) (60%) 1076 1035 OIT FOUND OIT PREDICTED220° C. wt. g wt. g wt. g wt. g min. avg. min.__________________________________________________________________________Kaydol, 86.53 g 1.17 0.3 32.90 1.17 0.3 34.65 1.17 0.3 35.80 34.4 24.9Kaydol, 85.87 g 1.83 0.3 34.50 1.83 0.3 33.60 1.83 0.3 30.50 32.9 38.0Kaydol, 85.87 g 1.83 0.3 57.20 1.83 0.3 56.10 1.83 0.3 56.10 56.5 60.0Kaydol, 86.53 g 1.17 0.3 54 1.17 0.3 48.3 1.17 0.3 46.3 49.5 46.9Kaydol, 86.00 g 1.7 0.3 34.15 1.7 0.3 32.51 1.7 0.3 27.74 31.5 32.2Kaydol, 86.7 g 1 0.3 47.67 1 0.3 43.55 1 0.3 44.12 45.1 43.5__________________________________________________________________________
The optimum concentrations of antioxidants in the stabilization system of the present invention were derived from linear regression of the data developed from experiments listed in TABLE I. As an example, a filling compound formulation used included mineral oil, Kaydol (in the amounts depicted in TABLE I), 6% by weight of Kraton 1701, 6% by weight of Cab-O-Sil TS-720 and varying levels of antioxidants.
In general, the oxidative induction time (OIT) value is an indication of the time when the material being tested begins to oxidize. Therefore, the higher the OIT value, the slower the material begins to oxidize. In other words, an antioxidant system with a higher OIT would inhibit oxidation better than a system with a lower OIT value. The antioxidant system of the present invention improves the performance of the oil. The oxidative induction time of the oil of the composition increases with the use of this antioxidant system.
The OIT may be determined by differential scanning calorimetry. Specifically, a thermal analyzer equipped with differential scanning calorimetric cells manufactured by TA Instruments of New Castle, Del. (formerly known as E. I. DuPont Instruments) was used to measure the OIT values presented herein. Furthermore, as stated, the particular antioxidant evaluated as presented in TABLE II included Lubrizol 1395, which is a zinc C1 -C14 alkyldithiophosphate, Irganox 1076, which is a hindered phenol manufactured by Ciba-Geigy, and Irganox 1035.
The oil constituent needs to be thickened so that it will not run out of a cable and so that oil separation is reduced. Oil separation or syneresis is a property of a filling material which describes the tendency to bleed oil during the lifetime of the filling material. One prior art filling material is known to separate oil if left undisturbed for a certain period of time. The syneresis is usually a slow process and, therefor, has to be determined by an accelerated method, centrifugation. As mentioned hereinbefore, it is desired that the filling material 26 be characterized by a 5% maximum oil separation when centrifuged at a rotational speed equivalent to a relative centrifugal force of 26,000 G for two hours. In order to accomplish this, inorganic and organic thickening agents are included in the composition of the filling material.
Colloidal fillers are used as inorganic thickening agents to adjust the yield stress of the composition. Colloidal filler particles in oil gel the oil by bonding surface hydroxyl groups to form a network. Such gels are capable of supporting a load below a critical value of stress. Above this stress level, the network is disrupted, and the material assumes a liquid-like character and flows under stress. Such behavior often is referred to as thixotropic and is desirable to facilitate processing.
Colloidal fillers useful in the cable 20 include colloidal silica, either hydrophilic or hydrophobic, preferably a hydrophobic fumed silica having a BET surface area between about 50 and about 400 m2 /gm. The higher the surface area, the lower the oil separation. An increase in the fumed silica level decreases oil separation, but adversely increases the critical yield stress and the viscosity of the grease. An example of a hydrophobic fumed silica is a polydimethylsiloxane-coated fumed silica having a BET surface area of about 80-120 m2 /gm, containing about 5% b.w. carbon, and being available from the Cabot Corporation of Tuscola, Ill. under the trade designation Cab-O-Sil TS720. An exemplary hydrophilic colloidal material is fumed silica with a BET surface area of about 175-225 m2 /gm, nominal particle size of 0.012 μm, and a specific gravity of 2.2, available form the Cabot Corporation under the designation Cab-O-Sil M-5. Other colloidal fillers that may be useful in the practice of the invention are precipitated silicas and clays such as bentonites, with or without surface treatment. In the preferred embodiment, a hydrophobic fumed silica such as the Cab-O-Sil TS720 fumed silica in the amount of about 4 to 8 percent by weight is used as the inorganic thickening agent.
Oil retention of the filling material 26 may be improved by the addition of one of more organic thickening agents or bleed inhibitors to the composition. Copolymers used as bleed inhibitors are known to reduce the oil separation of a grease-like filling material, and, unlike fumed silica, does not contribute as much to increasing yield stress and viscosity.
The bleed inhibitor may be a block copolymer, a relatively high viscosity semiliquid, sometimes referred to as semisolid, rubber, or other appropriate rubber. Block copolymers and semiliquid rubbers may be referred to collectively as rubber polymers. Incorporating a rubber polymer into the grease-like composition of matter allows a reduction in the amount of colloidal particles that must be added to the mixture to prevent syneresis of the gel and can result in cost savings. Furthermore, it makes possible the formulation of nonbleeding compositions having a relatively low critical yield stress.
Among the block copolymers that can be used in waterblocking compositions for the cable of the invention are styrene-rubber and styrene-rubber-styrene block copolymers having a styrene/rubber ratio between approximately 0.1 and 0.8 and a molecular weight, as indicated by viscosity in toluene at 25° C., of from about 100 cps in a 20% b.w. rubber solution to about 2000 cps in a 15% b.w. rubber solution. Exemplary block copolymers are (a) a styrene-ethylene-propylene block copolymer (SEP), unplasticized, having a styrene/rubber ratio of about 0.59, a specific gravity of about 0.93, a break strength per ASTM D-412 of 300 psi, and being available from the Shell Chemical Company of Houston, Tex., under the trade designation Kraton G1701; (b) a styrene-ethylene-propylene block copolymer having a styrene to rubber ratio of about 0.39 and available from the Shell Chemical Company under the designation G1702; (c) styrene-ethylene butylene-styrene block copolymer (SEBS), unplasticized, and having a styrene/rubber ratio of about 0.16, a specific gravity of about 0.90, 750% elongation, 300 % modulus per ASTM D-412 of 350 psi, and being available from the Shell Chemical Corporation under the trade designation Kraton G1657 and (d) a diblock copolymer of ethylene and propylene (EP) available from the Shell Chemical Company under the designation G1750. Another copolymer which may be used is Kraton 1726 copolymer which is a mixture of 30% styrene-ethylene butylene-styrene triblock copolymer (SEBS) and 70% styrene-ethylene butylene diblock copolymer (SEB). The preferred embodiment includes Kraton G 1701 block copolymer in an amount of about 6 percent by weight.
It is to be understood that the above-described arrangements are simply illustrative of the invention. Other arrangements may be devised by those skilled in the art which will embody the principles of the invention and fall within the spirit and scope thereof.